MAXIND

Max India Limited Investor Release Q4 & FY21 www.maxindia.com EimA) c, INDIA LIMITED ANTARA SENIOR LIVING tmAxl INDIA Max India : Key Highlights LIMITED 1 Capital reduction update: In-principle approval received from Stock exchanges and SEBI had advised Sponsors to seek exemption from Open Offer under automatic route; Postal ballot approval from shareholders and NCLT filing to be • initiated in Jun’21. NCLT approval and final closing expected in Q3FY22 2 Max India has sufficient Treasury Corpus of Rs 402 Cr to support Antara’s growth and Capital reduction (Rs 92 Cr) ■ Care at Home: Net revenue at Rs 1.2 Cr, 19% growth q-o-q. Improved revenue trajectory due to launch of multiple 3 service lines- Critical care, Physio, Path; Pivoted and launched COVID products & Dehradun launched in Q3FY21 Care Homes : Second Care Home launched in G.K.(South Delhi) in Q3FY21; Net revenue at Rs 0.6 Cr, 96% growth q-o-q 4 (Business impacted due to COVID – hospital occupancy and International travel ban) 5 MedCare: The business line launched in Q3FY21, Net revenue at Rs 0.5 Cr, 119% growth q-o-q Dehradun : Cumulative units sold at 142 (FY20 124) and Sales collections at INR 396 Cr (FY20 INR 340 Cr) as of Mar’21, monetised P1 land parcel for Rs 41 Cr, Rs 15 Cr already received, deal closure expected by Q2FY22 6 Noida: Cumulative units sold at 153 (FY20 27) and Sales collections at INR 32 Cr (FY20 INR 2 Cr) as of Mar’21 2 Antara “Who We Are” ANTARA Care Residences _A Max Group Company Homes for seniors Specialised residential Safe, secure and hassle-free facilities for short & long term residential communities providing care, pre & post-operative wellness, engagement and care and memory care, recreation services for seniors Senior living Assisted living communities Antara's Vision for seniors is to be the most loved and trusted brand for seniors and their families by helping them to improve and enrich their quality of life MedCare Care Products at Home W-de range of Comprehensive medical care medical equipment and assistance for seniors, to aid recovery delivered in the comfort of and well-being their home Medical equipment Healthcare services and products at home AN IAR Senior care starts with us 3 A Max Group Company, This information was prepared by Antara Senior Living Ltd. It is not to be used or relied upon by any 3rd party without Antara’s written consent. Care at Home revenue at Rs 1.2 Cr in Q4 and closes at Rs 2.6 Cr in FY21 r Revenue and Volume trend 4500 150.0 119.1 100.5 3000 100.0 33.2 1500 50.0 4.5 1,600 3,000 4,200 ~ ~ 300 0 0.0 Q1FY21 Q2FY21 Q3FY21 Q4FY21 Volume served (nos) Revenue (Rs lacs) FY21 Contribution from Care at Home ~11.5% (Rs 30 lacs) 1. LongstayservicesrevenueatRs2.3Cr,DiagnosticsrevenueatRs0.3CrforFY21 2. LongstayconsistsofNursing,criticalcare,Physiotherapyandmedicalattendant AACS Capital deployed till FY21 Rs 19 Cr, Committed capital for FY22 Rs 70 Cr & Peak capital requirement Rs 225 Cr (a)Revenuereportedaboveisonnetbasisafterdiscounts (b)Contributionisderivedatbyallocatingalldirectcostsattributabletotherespectivebusinesslines.[Contribution=(Gross revenuelessdiscounts)–(Directcosts)] ►7>ANTARA 4 A Max Group Company Care Homes revenue doubles to Rs 0.6 Cr in Q4 sequentially q-o-q and touches Rs 0.9 Cr revenue in FY21 r Revenue and Volume trend 8000 80.0 6,300 6000 60.0 55.2 4,274 4000 40.0 2,720 28.1 4.3% 2000 20.0 777 6.5 350 ~ 177 ~ 0 0.0 ~Q2FY21 ~ Q3FY21 Q4FY21 Available (bed days) Occupied (bed days) Revenue (Rs lacs) FY21 Contribution from Care Homes -227% (- Rs 2.04 Crs) 1. FY21Revenue:GurgaonCareHomeRs0.7CrandGKCareHomeatRs0.2Cr 2. Q4’21occupancyforGurgaonat20%andGKat6%(GGNoperationaleffective8thJuly’2OandGKoperationaleffective27thNov’20) 3. Centerbreak-evenexpectedat~50-55%occupancy AACS Capital deployed till FY21 Rs 19 Cr, Committed capital for FY22 Rs 70 Cr & Peak capital requirement Rs 225 Cr (a)Revenuereportedaboveisonnetbasisafterdiscounts (b)Contributionisderivedatbyallocatingalldirectcostsattributabletotherespectivebusinesslines.[Contribution=(Gross revenuelessdiscounts)–(Directcosts)] ,>ANTARA 5 A Max Group Company MedCare business line launched in Q3FY21: First retail store launched in Fortis Hospital Gurugram in Dec’20 Revenue trend I. PROUD TO ANNOUNCE 47.3 THE LAUNCH OF Agtara, Medi:are. Stare 21.6 In Fortis Memorial Research Institute, Sec - 44, Gurugram 6.8 ffSeniorCareStartsWithUs Q2FY21 Q3FY21 Q4FY21 Revenue (Rs lacs) Medeare Pro,], Key Highlights IMO VTh"to I McdCare Products • • Comprehensive range of products across 5 key categories (over ~800 SKUs) Bispieusch am arl 11.10 e • Rehabilitation e • Respiratory i*ult '2.4' r I 1171 • Mobility fl • Bathroom Accessories • Preventive & Wellness • Rental option for select medical equipment • Revenue of Rs 77 lacs in FY21 NIcdCare Pnrlurix • Contribution margin ~ 11% (Rs 8 lacs) in FY21 Note:Revenuereportedaboveisonnetbasisafterdiscounts 6 A Max Group Company Two Care Homes launched (Gurgaon & GK II) in the last 9 months Gurgaon: 26 rooms with single/ twin occupancy, suites GK II: 32 rooms with single/ twin occupancy, suites lot ft/ r re I 00• I Care HH omes Iry AIt r 9811 44 n •4 ` 7N1 \ 6 \ . 4.t.flfr-' i= t cl>AN I. 7 4, A Tiel)ix Group Curnpany This information was prepared by Antara Senior Living Ltd. It is not to be used or relied upon by any 3rd party without Antara’s written consent. Antara Dehradun: Cumulative net sales at 142; Net collections at INR 396 Cr as of Mar’21 Key highlights: • Sales: maintained a net sales velocity ~2.67 per month Cumulative sales and collection trend (for last three months) 400 Available units –197; Saleable area (sq ft) : ~ 5,75,500 396 150 • Focus on virtual meetings 142 Impacted by COVID 375 • Resident referrals 140 375 134 • Channel partners now active in Doon 351 130 350 340 340 130 124 124 • Pricing: Avg. sales realisation ~Rs 13,250/sq ft in FY21 120 325 • Collections: Maintained a robust monthly collection trend 110 300 of ~INR 7 Cr per month Q4FY20 Q1FY21 Q2FY21 Q3FY21 Q4FY21 MN= Collection (Rs Cr) Units sold (nos) • Debt : Debt outstanding as at Mar’21 end: Rs 123 Cr i ANTA RA 8 A Max Group Company Antara Noida: Cumulative net sales at 153; Net collections at INR 32 Cr as of Mar’21 Cumulative sales and collection trend Key highlights: 40 180 Phase I Available units –340; Saleable area (sq ft): ~ 7,45,000 153 • Sales: maintained a net sales velocity of ~6.33 per month (for 134 32 30 135 last three months) 111 23 • Re-oriented marketing efforts - sharp focus on digital, leveraging Impacted by COVID 20 90 quality of life elements of Antara 15 • Healthy pipeline of hot & warm clients in place 38 10 45 27 • Over 92% collections within time 2 2 • Pricing: Avg. sales realisation ~Rs 7,000 per sq ft in 12MFY21 1 1 4 - 0 Q4FY20 Q1FY21 Q2FY21 Q3FY21 Q4FY21 • Project cost for Phase 1 (incl. Land) over next 4 years : Rs L Collection (Rs Cr) Units sold (nos) 330 Cr • Project update: Excavation for R1 and R2 completed, Piling for Payment plan (break-up basis units sold) R1 started, PMC on board, construction to commence from 7% Q2FY22 25% • Phase 1 Project completion expected by Mar’25 • Equity Funding (including Rs 31 Cr for Phase II) : 59% • Equity invested till Mar’21 : Rs 27 Cr 6% 3% • Committed capital for FY22 : Rs 40 Cr • Peak equity requirement : Rs 74 Cr Down Payment Construction Linked 10:20:30:40 I 10:20:70 ■ 10:90 0 >ANTARA 9 Z A Max Group Company Disclaimer This presentation has been prepared by Max India Limited (the “Company”). No representation or warranty, express or implied, is made and no reliance should be placed on the accuracy, fairnessorcompletenessoftheinformationpresentedorcontainedin thepresentation. Thepastperformanceisnotindicativeoffutureresults. Neither theCompanynor any ofitsaffiliates,advisersorrepresentativesacceptsliabilitywhatsoeverforanylosshowsoeverarisingfromanyinformationpresentedorcontainedinthepresentation.Theinformation presentedorcontainedinthesematerialsissubjecttochangewithoutnoticeanditsaccuracyisnotguaranteed. Thepresentationmayalsocontainstatementsthatareforwardlooking.Thesestatementsarebasedoncurrentexpectationsandassumptionsthataresubjecttorisksanduncertainties. Actual results could differ materially from our expectations and assumptions. We do not undertake any responsibility to update any forward looking statements nor should this be constitutedasaguidanceoffutureperformance. Thispresentationdoesnotconstituteaprospectusorofferingmemorandumoranoffertoacquireanysecuritiesandisnotintendedtoprovidethebasisforevaluationofthesecurities. Neither this presentation nor any otherdocumentation or information (or any part thereof)delivered or supplied underor in relation to the securities shall bedeemed to constitute an offeroforaninvitation. No person is authorised to give any information or to make any representation not contained in and not consistent with this presentation and, if given or made, such information or representationmustnotberelieduponashavingbeenauthorisedbyoronbehalfoftheCompanyanyofitsaffiliates,advisersorrepresentatives. TheCompany’s Securities have notbeen and arenot intended to beregistered under theUnited States Securities Actof 1993, as amended (the“Securities Act”), or any State Securities Law and unless so registered may not be offered or sold within the United States or to, or for the benefit of, U.S. Persons (as defined in Regulations S under the Securities Act) except pursuanttoanexemptionfrom,orinatransactionnotsubjectto,theregistrationrequirementsoftheSecuritiesActandtheapplicableStateSecuritiesLaws. This presentation is highly confidential, and is solely for your information and may not be copied, reproduced or distributed to any other person in any manner. Unauthorized copying, reproduction, or distribution of any of the presentation into the U.S. or to any “U.S. persons” (as defined in Regulation S under the Securities Act) or other third parties ( including journalists)couldprejudice,anypotentialfutureofferingofsharesbytheCompany.Youagreetokeepthecontentsofthispresentationandthesematerialsconfidential. I 10